267 filings
Page 4 of 14
8-K
SPHS
Sophiris Bio Inc.
28 Jun 18
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
SPHS
Sophiris Bio Inc.
25 Jun 18
Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer
9:00am
10-Q
2018 Q1
SPHS
Sophiris Bio Inc.
Quarterly report
14 May 18
4:11pm
8-K
SPHS
Sophiris Bio Inc.
14 May 18
Sophiris Bio Reports First Quarter 2018 Financial Results and Key Corporate Highlights
4:05pm
DEFA14A
SPHS
Sophiris Bio Inc.
27 Apr 18
Additional proxy soliciting materials
4:06pm
DEF 14A
SPHS
Sophiris Bio Inc.
Definitive proxy
27 Apr 18
4:05pm
10-K
2017 FY
SPHS
Sophiris Bio Inc.
Annual report
21 Mar 18
12:00am
8-K
SPHS
Sophiris Bio Inc.
21 Mar 18
Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights
12:00am
CT ORDER
SPHS
Sophiris Bio Inc.
15 Dec 17
Confidential treatment order
12:00am
4
SPHS
Sophiris Bio Inc.
8 Dec 17
SOPHIRIS BIO / RANDALL E WOODS ownership change
12:00am
4
Allison Hulme
8 Dec 17
SOPHIRIS BIO / ALLISON HULME ownership change
12:00am
8-K
SPHS
Sophiris Bio Inc.
8 Dec 17
Departure of Directors or Certain Officers
12:00am
4
SPHS
Sophiris Bio Inc.
8 Dec 17
SOPHIRIS BIO / Peter T Slover ownership change
12:00am
10-Q
2017 Q3
SPHS
Sophiris Bio Inc.
Quarterly report
9 Nov 17
12:00am
8-K
SPHS
Sophiris Bio Inc.
9 Nov 17
Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights
12:00am
8-K
SPHS
Sophiris Bio Inc.
13 Sep 17
Entry into a Material Definitive Agreement
12:00am
EFFECT
SPHS
Sophiris Bio Inc.
30 Aug 17
Notice of effectiveness
12:00am
CORRESP
SPHS
Sophiris Bio Inc.
28 Aug 17
Correspondence with SEC
12:00am
S-3/A
SPHS
Sophiris Bio Inc.
24 Aug 17
Shelf registration (amended)
12:00am
8-K
SPHS
Sophiris Bio Inc.
10 Aug 17
Sophiris Bio Reports Second Quarter Financial Results and Key Corporate Highlights
12:00am